{"id":147064,"date":"2023-05-23T04:07:01","date_gmt":"2023-05-23T08:07:01","guid":{"rendered":"https:\/\/44.250.171.167\/?p=147064"},"modified":"2023-05-23T04:07:02","modified_gmt":"2023-05-23T08:07:02","slug":"earnings-chemcrux-enterprises-limited-bse-540395-q4fy23-results-out-total-income-fell-26-yoy","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/earnings-chemcrux-enterprises-limited-bse-540395-q4fy23-results-out-total-income-fell-26-yoy\/","title":{"rendered":"Earnings | Chemcrux Enterprises Limited (BSE: 540395): Q4FY23 Results Out; Total Income fell 26% YoY."},"content":{"rendered":"\n

Chemcrux Enterprises Limited, incorporated in April 1996, is a company engaged in the manufacturing of bulk drug intermediates. Their product range includes Para Chloro Benzoic, Ortho Benzoic Acid, and Lasamide, among others. With a focus on the pharmaceutical industry, Chemcrux Enterprises plays a crucial role in supplying essential intermediates used in the production of various drugs. By ensuring the quality and reliability of their products, the company contributes to the overall pharmaceutical supply chain. With their expertise in bulk drug intermediates, Chemcrux Enterprises serves as a trusted partner for pharmaceutical manufacturers, supporting the development and production of vital medications.
\u2022 Chemcrux Enterprises Limited reported Total Income for Q4 FY23 of \u20b920 Crore down from \u20b927 Crore year on year, a negative growth of 26%.
\u2022 Total Expenses for Q4 FY23 of \u20b916 Crore down from \u20b921 Crore year on year, a negative growth of 24%.
\u2022 Consolidated Net Profit of \u20b93 Crore, down 33% from \u20b94.5 Crore in the same quarter of the previous year.
\u2022 The Earnings per Share is \u20b91.97, down 35% from \u20b93.06 in the same quarter of the previous year.<\/p>\n\n\n\n

\"\"<\/figure>\n","protected":false},"excerpt":{"rendered":"

Chemcrux Enterprises Limited, incorporated in April 1996, is a company engaged in the manufacturing of bulk drug intermediates. Their product range includes Para Chloro Benzoic, Ortho Benzoic Acid, and Lasamide, among others. With a focus on the pharmaceutical industry, Chemcrux Enterprises plays a crucial role in supplying essential intermediates used in the production of various […]<\/p>\n","protected":false},"author":1932,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[392],"tags":[1115],"class_list":["post-147064","post","type-post","status-publish","format-standard","hentry","category-earnings","tag-pharmaceuticals"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":144444,"url":"https:\/\/alphastreet.com\/india\/earnings-summary-of-iol-chemicals-pharmaceuticals-for-q4-fy23\/","url_meta":{"origin":147064,"position":0},"title":"Earnings Summary Of IOL Chemicals & Pharmaceuticals For Q4 FY23","author":"Hardik Bhandare","date":"April 28, 2023","format":false,"excerpt":"IOL Chemicals & Pharmaceuticals Limited is an Indian-based pharmaceutical company engaged in the manufacturing and marketing of bulk drugs and organic chemicals. The company has a diverse product portfolio, including Ibuprofen, Metformin, Lamotrigine, and various other APIs and intermediates used in the pharmaceutical, food, and animal feed industries. IOL Chemicals\u2026","rel":"","context":"In "Earnings"","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/04\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-5-1.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/04\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-5-1.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/04\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-5-1.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/04\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-5-1.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/04\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-5-1.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/04\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-5-1.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":147094,"url":"https:\/\/alphastreet.com\/india\/earnings-summary-of-dishman-carbogen-amcis-limited-for-q4-fy23\/","url_meta":{"origin":147064,"position":1},"title":"Earnings Summary Of Dishman Carbogen Amcis Limited For Q4 FY23","author":"Hardik Bhandare","date":"May 23, 2023","format":false,"excerpt":"Dishman Carbogen Amcis Limited is a global pharmaceutical contract development and manufacturing organization (CDMO) that specializes in the development and manufacturing of active pharmaceutical ingredients (APIs), intermediates, and specialized drug products. With over three decades of experience, the company has established itself as a trusted partner for pharmaceutical companies worldwide.\u2026","rel":"","context":"In "Earnings"","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-3-8.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-3-8.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-3-8.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-3-8.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-3-8.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-3-8.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":146247,"url":"https:\/\/alphastreet.com\/india\/earnings-summary-of-granules-india-limited-for-q4-fy23\/","url_meta":{"origin":147064,"position":2},"title":"Earnings Summary Of Granules India Limited For Q4 FY23","author":"Hardik Bhandare","date":"May 16, 2023","format":false,"excerpt":"Granules India Limited is a pharmaceutical manufacturing company based in India. The company is engaged in the production and sale of active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates (PFIs), and finished dosages (FDs). With a strong focus on quality, innovation, and customer satisfaction, Granules India has established itself as a\u2026","rel":"","context":"In "Earnings"","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-2-5.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-2-5.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-2-5.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-2-5.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-2-5.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-2-5.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":147292,"url":"https:\/\/alphastreet.com\/india\/earnings-divis-laboratories-ltd-nse-divislab-q4fy23-results-out-total-income-fell-21-yoy\/","url_meta":{"origin":147064,"position":3},"title":"Earnings | Divis Laboratories Ltd (NSE: DIVISLAB): Q4FY23 Results Out; Total Income fell 21% YoY.","author":"Divyansh_Kasana","date":"May 25, 2023","format":false,"excerpt":"Divis Laboratories Ltd is a renowned Indian company specializing in the production and global export of Active Pharmaceutical Ingredients (APIs), Intermediates, and Nutraceutical ingredients. With a solid reputation in the pharmaceutical industry, the company has established itself as a leading manufacturer of high-quality chemicals. Divis Laboratories focuses on research, development,\u2026","rel":"","context":"In "Earnings"","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/4b0b185d-fd09-4e7e-947d-ef141089055f-5-4.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/4b0b185d-fd09-4e7e-947d-ef141089055f-5-4.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/4b0b185d-fd09-4e7e-947d-ef141089055f-5-4.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/4b0b185d-fd09-4e7e-947d-ef141089055f-5-4.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/4b0b185d-fd09-4e7e-947d-ef141089055f-5-4.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/4b0b185d-fd09-4e7e-947d-ef141089055f-5-4.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":144359,"url":"https:\/\/alphastreet.com\/india\/laurus-labs-limited-q4fy23-earnings\/","url_meta":{"origin":147064,"position":4},"title":"Laurus Labs Limited Q4FY23 Earnings","author":"Karan_Singh","date":"April 27, 2023","format":false,"excerpt":"To meet the demands of the international pharmaceutical industry, Laurus Labs primarily provides a comprehensive and integrated portfolio of Active Pharmaceutical Ingredients (API), including intermediates, Generic Finished Dosage Forms (FDF), and Contract Research services. Financial Results: Laurus Labs Ltd. reported Total Income for Q4FY23 of \u20b9 1,382.61 Crores down from\u2026","rel":"","context":"In "Earnings"","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/10\/science-lab_evotec_-Macrovector.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/10\/science-lab_evotec_-Macrovector.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/10\/science-lab_evotec_-Macrovector.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/10\/science-lab_evotec_-Macrovector.jpg?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":181349,"url":"https:\/\/alphastreet.com\/india\/emerging-api-and-intermediates-maker-focuses-on-scale-post-listing\/","url_meta":{"origin":147064,"position":5},"title":"Emerging API and Intermediates Maker Focuses on Scale Post-Listing","author":"Staff Correspondent","date":"February 19, 2026","format":false,"excerpt":"Anlon Healthcare Ltd (NSE: AHCL), a relatively recent entrant to the public markets following its 2025 IPO, reported its Q3 FY2026 earnings as it continues scaling operations in pharmaceutical intermediates and APIs. The company\u2019s market capitalisation stands at approximately \u20b9600\u2013650 crore based on recent estimates. Growth Anchored in Pharma Supply\u2026","rel":"","context":"In "LATEST"","block_context":{"text":"LATEST","link":"https:\/\/alphastreet.com\/india\/category\/latest\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/147064","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1932"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=147064"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/147064\/revisions"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=147064"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=147064"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=147064"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}